Literature DB >> 3286157

Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia.

E Bonora1, C Rizzi, C Lesi, P Berra, C Coscelli, U Butturini.   

Abstract

The aim of the present study was to evaluate insulin secretion by the pancreatic B cell in a group of patients with severe chronic pancreatitis and without overt diabetes. For this purpose we have measured plasma insulin and C-peptide peripheral levels in the fasting state and after a 100-g oral glucose load in 10 patients with severe chronic pancreatitis and fasting normoglycemia, and in 10 sex-, age-, and weight-matched healthy controls. As compared to normal subjects, patients with chronic pancreatitis showed: (1) significantly higher plasma glucose levels after oral glucose load (area under the plasma glucose curve 1708 +/- 142 vs 1208 +/- 47 mmol/liter X 240 min, P less than 0.005); (2) plasma insulin levels significantly higher at fasting (0.11 +/- 0.008 vs 0.08 +/- 0.005 nmol/liter, P less than 0.01) but not after oral glucose administration (area under the plasma insulin curve 79 +/- 12 vs 88 +/- 16 nmol/liter X 240 min); (3) significantly lower plasma C-peptide concentrations both in the fasting state (0.15 +/- 0.01 vs 0.54 +/- 0.05 nmol/liter, P less than 0.001) and after oral glucose load (area under the plasma C-peptide curve 211 +/- 30 vs 325 +/- 37 nmol/liter X 240 min, P less than 0.05). The finding of diminished plasma C-peptide levels suggests that chronic pancreatitis is associated with an impaired B-cell function even in the absence of overt diabetes. The increased or unchanged plasma insulin levels in spite of decreased plasma C-peptide concentrations indicate that in chronic pancreatitis insulin metabolism is reduced, most likely within the liver.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286157     DOI: 10.1007/bf01540438

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  The insulin response to glucose in patients with pancreatic disease.

Authors:  M T McKiddie; K D Buchanan; G C McBain; G Bell
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

Review 2.  Chronic pancreatitis: clinical features and medical management.

Authors:  S Bank
Journal:  Am J Gastroenterol       Date:  1986-03       Impact factor: 10.864

3.  Plasma-insulin levels in "pancreatic diabetes".

Authors:  P Keller; S Bank; W P Jackson; I N Marks; I G O'Reilly
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

4.  Clinical and hormonal aspects of pancreatic diabetes.

Authors:  S Bank; I N Marks; A I Vinik
Journal:  Am J Gastroenterol       Date:  1975-07       Impact factor: 10.864

5.  Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.

Authors:  P R Bratusch-Marrain; W K Waldhäusl; S Gasić; A Hofer
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

6.  Degradation and secretion of insulin in hepatic cirrhosis.

Authors:  Y Iwasaki; A Ohkubo; H Kajinuma; Y Akanuma; K Kosaka
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

7.  Is glucose intolerance after pancreatitis related to pancreatic tissue damage?

Authors:  U Seligson; J W Cho; A Nygren; P Reichard
Journal:  Acta Med Scand       Date:  1983

8.  Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose.

Authors:  S Madsbad; H Kehlet; J Hilsted; B Tronier
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

9.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

Review 10.  Insulin degradation by insulin target cells.

Authors:  B J Goldstein; J N Livingston
Journal:  Metabolism       Date:  1981-08       Impact factor: 8.694

View more
  6 in total

1.  Exocrine and endocrine functional reserve in the course of chronic pancreatitis as studied by maximal stimulation tests.

Authors:  G Cavallini; P Bovo; M Zamboni; O Bosello; M Filippini; A Riela; G Brocco; L Rossi; C Pelle; A Chiavenato
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

2.  Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?

Authors:  Leticia M Nogueira; Christina C Newton; Michael Pollak; Debra T Silverman; Demetrius Albanes; Satu Männistö; Stephanie J Weinstein; Eric J Jacobs; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-17       Impact factor: 4.254

Review 3.  Chronic pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2012-09       Impact factor: 3.287

4.  Chronic Pancreatitis and Diabetes Mellitus.

Authors:  Yu Kuei Lin; Philip C Johnston; Karla Arce; Betul A Hatipoglu
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

5.  Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity.

Authors:  E F Lampeter; I Seifert; D Lohmann; J W Heise; J Bertrams; M R Christie; V Kolb-Bachofen; H Kolb
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

Review 6.  Mechanisms of Post-Pancreatitis Diabetes Mellitus and Cystic Fibrosis-Related Diabetes: A Review of Preclinical Studies.

Authors:  Eleonóra Gál; Jurij Dolenšek; Andraž Stožer; László Czakó; Attila Ébert; Viktória Venglovecz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.